Search - tctmd.com

Displaying 101 - 120 of 149

Sort: Relevancy | Date

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Daily News

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

L.A. McKeown

August 10, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Daily News

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

June 16, 2015

News Daily News

BRS Strut Width Tied to Increased Periprocedural MI

June 02, 2015

News Conference News EuroPCR 2015

PERFECT-2: Angioplasty Can Effectively Treat Erectile Dysfunction But Restenosis an Issue

Caitlin E. Cox

May 21, 2015

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

News Daily News

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

L.A. McKeown

November 06, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Very Small Vessels in the RESOLUTE Global Clinical Program

Presenter: Antonio Serra

September 16, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

Advertisement

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Boston Scientific Announces Scheduled Presentations At TCT 2015

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

COMPARE: EES Maintains Advantage Over PES at 5 Years

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

BRS Strut Width Tied to Increased Periprocedural MI

PERFECT-2: Angioplasty Can Effectively Treat Erectile Dysfunction But Restenosis an Issue

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

Percutaneous Coronary Intervention of Very Small Vessels in the RESOLUTE Global Clinical Program

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content